Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 4/20 | 0.55 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.55 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.55 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.55 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.44 |
| ▸ | MRGPRX4 | Q96LA9 | 9/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.43 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.42 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.42 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL723195 | 0.99 | PTGER1 (0.54) | PTGER1PTGER4PTGER3PTGER2MTNR1B | |
| SCHEMBL1901763 | 0.91 | PTGER1 (0.47) | PTGER1PTGER4PTGER3PTGER2MTNR1B | |
| SCHEMBL724700 | 0.87 | ADRB2 (0.39) | PTGER1PTGER4PTGER3PTGER2LTB4R | |
| SCHEMBL725913 | 0.86 | PTGER1 (0.58) | PTGER1PTGER4PTGER3PTGER2MTNR1B | |
| SCHEMBL7758338 | 0.86 | PTGER1 (0.46) | PTGER1PTGER4PTGER3PTGER2MTNR1B | |
| SCHEMBL722894 | 0.85 | PTGER1 (0.44) | PTGER1PTGER4PTGER3PTGER2MTNR1B | |
| Hydrochloric Acid SCHEMBL725095 | 0.85 | PTGER1 (0.57) | PTGER1PTGER4PTGER3PTGER2MTNR1B | |
| SCHEMBL11299423 | 0.84 | MAOA (0.44) | PTGER1PTGER4PTGER3PTGER2MTNR1B | |
| SCHEMBL6473875 | 0.83 | GRIN2D (0.41) | PTGER1PTGER4PTGER3PTGER2 | |
| SCHEMBL8321828 | 0.80 | PTGER1 (0.70) | PTGER1PTGER4PTGER3PTGER2MTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012098560-A2 | PROCESS FOR THE PREPARATION OF MUSCARINIC RECEPTOR ANTAGONIST | MSN LABORATORIES LIMITED (IN) | 2012-07-26 | — | — | WO | claimed |
| WO-2012025941-A2 | PROCESSES FOR THE PREPARATION OF FESOTERODINE | CADILA HEALTHCARE LIMITED (IN) | 2012-03-01 | — | — | WO | claimed |
| WO-2012098560-A2 | PROCESS FOR THE PREPARATION OF MUSCARINIC RECEPTOR ANTAGONIST | MSN LABORATORIES LIMITED (IN) | 2012-07-26 | — | — | WO | disclosed |
| WO-2012025941-A2 | PROCESSES FOR THE PREPARATION OF FESOTERODINE | CADILA HEALTHCARE LIMITED (IN) | 2012-03-01 | — | — | WO | disclosed |
| WO-2011141932-A2 | PROCESS FOR PREPARATION OF PHENOLIC MONOESTERS OF HYDROXYMETHYL PHENOLS | INTAS PHARMACEUTICALS LIMITED (IN) | 2011-11-17 | — | — | WO | disclosed |
| WO-2009037569-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF FESOTERODINE | ACTAVIS GROUP PTC EHF (IS) | 2009-03-26 | — | — | WO | disclosed |
| EP-2029523-A1 | ACCELERATED SYNTHESIS OF SUBSTITUTED HYDROXYMETHYL PHENOLS | Schwarz Pharma Ltd. (IE) | 2009-03-04 | — | — | EP | disclosed |
| EP-1940774-A1 | NEW SYNTHESIS OF SUBSTITUTED HYDROXYMETHYL PHENOLS | Schwarz Pharma Ltd. (IE) | 2008-07-09 | — | — | EP | disclosed |
| WO-2007140965-A1 | ACCELERATED SYNTHESIS OF SUBSTITUTED HYDROXYMETHYL PHENOLS | SCHWARZ PHARMA LTD. (IE) | 2007-12-13 | — | — | WO | disclosed |
| WO-2007137799-A1 | NEW SYNTHESIS OF SUBSTITUTED HYDROXYMETHYL PHENOLS | SCHWARZ PHARMA LTD. (IE) | 2007-12-06 | — | — | WO | disclosed |